Free Trial
NASDAQ:NEPH

Nephros Q1 2025 Earnings Report

Nephros logo
$3.36 -0.04 (-1.18%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$3.36 +0.01 (+0.15%)
As of 06/6/2025 04:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros EPS Results

Actual EPS
$0.05
Consensus EPS
-$0.01
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

Nephros Revenue Results

Actual Revenue
$4.88 million
Expected Revenue
$3.67 million
Beat/Miss
Beat by +$1.21 million
YoY Revenue Growth
N/A

Nephros Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Nephros' Q2 2025 earnings is scheduled for Thursday, August 7, 2025, with a conference call scheduled on Friday, August 8, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Nephros Earnings Headlines

Nephros to Host Analyst and Investor Virtual Event
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Nephros Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nephros? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nephros and other key companies, straight to your email.

About Nephros

Nephros (NASDAQ:NEPH), a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

View Nephros Profile

More Earnings Resources from MarketBeat